 |
3M Drug Delivery Systems |
United Kingdom |
 |
|
|
 |
4-Antibody Ltd |
Switzerland |
|
|
|
 |
4SC AG
(Frankfurt Stock Exchange:VSC) |
Germany |
|
|
|
 |
Abbott |
United States |
|
|
|
 |
Acacia Pharma |
United Kingdom |
|
|
|
 |
Activartis Biotech GmbH |
Austria |
|
|
|
 |
ActoGeniX NV |
Belgium |
|
|
|
 |
ADA InVivo BV |
Netherlands |
|
|
|
 |
Affibody |
Sweden |
|
|
|
 |
AFFiRiS AG |
Austria |
|
|
|
 |
Affitech A/S
(NASDAQ:AFFI) |
Denmark |
|
|
|
 |
AiCuris |
Germany |
|
|
|
 |
AIM Therapeutics Inc. |
Canada |
|
|
|
| |
Algiax Pharmaceuticals GmbH |
Germany |
|
|
|
 |
Allon Therapeutics
(Toronto Stock Exchange (TSX):NPC) |
Canada |
|
|
|
 |
Almetis |
France |
|
|
|
 |
Almirall |
Spain |
|
|
|
 |
AM-Pharma |
Netherlands |
|
|
|
 |
Amcure |
Germany |
|
|
|
 |
AMRI
(NASDAQ:AMRI) |
United States |
|
|
|
 |
Amsterdam Moleculair Therapeutics B.V.
(Euronext:AMT) |
Netherlands |
|
|
|
 |
Angiochem |
Canada |
|
|
|
| |
Antares Pharma |
United States |
|
|
|
 |
Antisense Pharma GmbH |
Germany |
|
|
|
 |
APEIRON Biologics AG |
Austria |
|
|
|
| |
AptaIT GmbH |
Germany |
|
|
|
 |
Aptalis Pharmaceutical Technologies |
United States |
|
|
|
 |
Aquapharm Biodiscovery Ltd |
United Kingdom |
|
|
|
 |
arGEN-X BV |
Netherlands |
|
|
|
 |
Astex Pharmaceuticals |
United States |
|
|
|
 |
AstraZeneca |
|
|
|
|
 |
Auris Medical AG |
Switzerland |
|
|
|
 |
AVEO Pharmaceuticals
(NASDAQ:AVEO) |
United States |
|
|
|
 |
Basilea
(SIX Swiss Exchange:BSLN) |
Switzerland |
|
|
|
 |
Bayer HealthCare Pharmaceuticals |
Germany |
|
|
|
 |
Benitec Limited
(Australian Securities Exchange:BLT) |
Australia |
|
|
|
 |
biocrea GmbH |
Germany |
|
|
|
| |
BioMarin Pharmaceutical
(NASDAQ:BMRN) |
United States |
|
|
|
 |
BIOMAY AG |
Austria |
|
|
|
 |
BIOPHARM GmbH |
Germany |
|
|
|
 |
Biotie Therapies Corp.
(OMX Helsinki Stock Exchange (O:BTH1V) |
Finland |
|
|
|
 |
Boehringer Ingelheim Biopharmaceuticals |
Germany |
|
|
|
|
Boehringer Ingelheim Licensing |
Germany |
|
|
|
 |
C10 Pharma |
Norway |
|
|
|
 |
CANGO Corporation |
Japan |
|
|
|
 |
Cardoz AB |
Sweden |
|
|
|
 |
Catalyst Biosciences |
United States |
|
|
|
 |
CeNeRx BioPharma, Inc. |
United States |
|
|
|
 |
Cerulean Pharma Inc. |
United States |
|
|
|
 |
CEVEC Pharmaceuticals GmbH |
Germany |
|
|
|
 |
Chimerix, Inc. |
United States |
|
|
|
 |
Chiome Bioscience |
Japan |
|
|
|
 |
Covagen AG |
Switzerland |
|
|
|
 |
Cristal Delivery |
Netherlands |
|
|
|
 |
Curetis AG |
Germany |
|
|
|
 |
CureVac GmbH |
Germany |
|
|
|
 |
Curis, Inc.
(NASDAQ:CRIS) |
United States |
|
|
|
 |
Cyclacel Pharmaceuticals
(NASDAQ:CYCC) |
United Kingdom |
|
|
|
 |
CytomX Therapeutics, Inc. |
United States |
|
|
|
 |
Debiopharm SA |
Switzerland |
|
|
|
 |
Delenex Therapeutics |
Switzerland |
|
|
|
 |
DNAVEC |
Japan |
|
|
|
 |
DSM BioSolutions |
Netherlands |
|
|
|
 |
Dyax Corp. |
United States |
|
|
|
 |
Dynamic Biosensors |
Germany |
|
|
|
 |
Eli Lilly and Company |
United States |
|
|
|
 |
Embera |
United States |
|
|
|
 |
Endoceutics Inc |
Canada |
|
|
|
 |
Ensemble Therapeutics Corp. |
United States |
|
|
|
 |
Eporgen Venture S.p.A. |
Italy |
|
|
|
 |
ethris GmbH |
Germany |
|
|
|
 |
Expression Pathology Inc. |
United States |
|
|
|
 |
f-star GmbH |
United Kingdom |
|
|
|
 |
Galantos Pharma GmbH |
Germany |
|
|
|
 |
Gallus BioPharmaceuticals |
United States |
|
|
|
 |
GeneFrontier Corporation |
Japan |
|
|
|
| |
GENFIT CORP
(Euronext:ALGFT) |
United States |
|
|
|
 |
Genkyotex SA |
Switzerland |
|
|
|
 |
Genmab, Inc.
(OMX Copenhagen Stock Exchange:GEN) |
United States |
|
|
|
 |
GENTICEL |
France |
|
|
|
 |
GlaxoSmithKline |
United Kingdom |
|
|
|
 |
Glycotope GmbH |
Germany |
|
|
|
 |
GP BioSciences Ltd. |
Japan |
|
|
|
 |
Gruenenthal GmbH |
Germany |
|
|
|
 |
GU Holding AB - INNOVITRO |
Sweden |
|
|
|
| |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt |
Germany |
|
|
|
 |
Hermo Pharma Oy |
Finland |
|
|
|
 |
Immunovaccine, Inc.
(Toronto Stock Exchange (TSX):IMV) |
Canada |
|
|
|
 |
InflammaGen Therapeutics |
United States |
|
|
|
| |
Innovacell Biotechnologie AG |
Austria |
|
|
|
 |
ioGenetics LLC |
United States |
|
|
|
 |
iPS Academia Japan, Inc. |
Japan |
|
|
|
 |
Ironwood Pharmaceuticals |
United States |
|
|
|
| |
ISA Pharmaceuticals |
Netherlands |
|
|
|
 |
Kymab Ltd |
United Kingdom |
|
|
|
| |
Labopharm Inc.
(Toronto Stock Exchange (TSX):DDS) |
Canada |
|
|
|
 |
Lead Discovery Center GmbH |
Germany |
|
|
|
 |
Life & Brain GmbH |
Germany |
|
|
|
| |
Link Genomics, Inc. |
Japan |
|
|
|
 |
Lipopharma Therapeutics |
Spain |
|
|
|
 |
Lonza |
Switzerland |
|
|
|
 |
MacroGenics, Inc. |
United States |
|
|
|
| |
MEABCO |
Denmark |
|
|
|
 |
Merck Serono |
Switzerland |
|
|
|
 |
Merus B.V. |
Netherlands |
|
|
|
 |
Micromet GmbH
(:MITI) |
Germany |
|
|
|
 |
Mivac Development AB - TOLERANCE project |
Sweden |
|
|
|
 |
Mivac Development AB- ALZINOVA project |
Sweden |
|
|
|
 |
MMD, Metagenome and Metabolic Disease |
Sweden |
|
|
|
 |
Moberg Derma
(OMX Stockholm Stock Exchange:MOB) |
Sweden |
|
|
|
 |
Molmed S.p.A.
(Milan Stock Exchange (Borsa It:MLM) |
Italy |
|
|
|
| |
MOLOGEN AG
(Frankfurt Stock Exchange:MGN) |
Germany |
|
|
|
 |
MorphoSys AG
(:MOR) |
Germany |
|
|
|
 |
MSD |
Switzerland |
|
|
|
 |
multimmune GmbH |
Germany |
|
|
|
 |
National MS Society and Fast Forward, LLC |
United States |
|
|
|
 |
NB Health Laboratory Co.LTD. |
Japan |
|
|
|
 |
Neurotune AG |
Switzerland |
|
|
|
 |
Novartis |
Switzerland |
|
|
|
 |
Novo Nordisk |
Denmark |
|
|
|
 |
NOXXON Pharma AG |
Germany |
|
|
|
 |
Nycomed, a Takeda Company |
Switzerland |
|
|
|
 |
Omnia Molecular |
Spain |
|
|
|
 |
Oncolix, Inc. |
United States |
|
|
|
 |
Oncorena AB |
Sweden |
|
|
|
 |
Oncos Therapeutics |
Finland |
|
|
|
 |
ORCA Therapeutics |
Netherlands |
|
|
|
 |
Oxford BioMedica |
United Kingdom |
|
|
|
 |
Oxford BioTherapeutics Ltd |
United Kingdom |
|
|
|
 |
Pantec Biosolutions AG |
Liechtenstein |
|
|
|
 |
Pergamum |
Sweden |
|
|
|
 |
Pevion Biotech |
Switzerland |
|
|
|
 |
Phage Pharmaceuticals |
United States |
|
|
|
 |
PharmAbcine, Inc. |
South Korea |
|
|
|
 |
PhaseBio Pharmaceuticals Inc. |
United States |
|
|
|
 |
Phenex AG |
Germany |
|
|
|
 |
Piqur Therapeutics AG |
Switzerland |
|
|
|
 |
PolyMedix, Inc.
(OTC Bulletin Board (OTCBB):PYMX) |
United States |
|
|
|
 |
Polyrizon Ltd. |
Israel |
|
|
|
 |
PolyTherics Ltd |
United Kingdom |
|
|
|
 |
PrevenTec, Inc |
Japan |
|
|
|
 |
Probiodrug AG |
Germany |
|
|
|
 |
ProtAffin AG |
Austria |
|
|
|
 |
Protagen AG |
Germany |
|
|
|
 |
Provecs Medical |
Germany |
|
|
|
 |
Provesica Ltd |
United Kingdom |
|
|
|
 |
Ramot at Tel Aviv University Ltd. |
Israel |
|
|
|
 |
Rentschler Biotechnologie GmbH |
Germany |
|
|
|
 |
Resverlogix Corp.
(Toronto Stock Exchange (TSX):RVX) |
Canada |
|
|
|
 |
Reviva Pharmaceuticals, Inc. |
United States |
|
|
|
 |
Roche Group |
Switzerland |
|
|
|
 |
Roslin Cells |
United Kingdom |
|
|
|
 |
SANIFIT |
Spain |
|
|
|
 |
Sanofi |
France |
|
|
|
 |
Santhera Pharmaceuticals
(SIX Swiss Exchange:SANN) |
Switzerland |
|
|
|
 |
Scil Proteins GmbH |
Germany |
|
|
|
 |
Selexis SA |
Switzerland |
|
|
|
 |
Selvita S.A. |
Poland |
|
|
|
| |
Sheltagen Medical ltd |
Israel |
|
|
|
 |
Shire |
United States |
|
|
|
 |
Signature Diagnostics AG |
Germany |
|
|
|
 |
Silence Therapeutics
(London Stock Exchange (LSE):SLN) |
Germany |
|
|
|
 |
SK Biopharmaceuticals |
United States |
|
|
|
 |
Spinifex Pharmaceuticals Pty Ltd |
Australia |
|
|
|
 |
Stemergie Biotechnology SA |
Switzerland |
|
|
|
 |
sterna biologicals GmbH & Co. KG |
Germany |
|
|
|
 |
Sunesis Pharmaceuticals, Inc.
(NASDAQ:SNSS) |
United States |
|
|
|
 |
SuSoS AG |
Switzerland |
|
|
|
 |
SYGNIS Pharma AG
(Frankfurt Stock Exchange:LIOK) |
Germany |
|
|
|
 |
Syntaxin Ltd |
United Kingdom |
|
|
|
 |
TagCyx Biotechnologies |
Japan |
|
|
|
| |
TikoMed AB |
Sweden |
|
|
|
 |
Tissue Med Biosciences |
Austria |
|
|
|
 |
University of Bristol |
United Kingdom |
|
|
|
 |
US Army Medical Research and Materiel Command |
United States |
|
|
|
 |
Vectura Group plc |
United Kingdom |
|
|
|
 |
Vetter |
Germany |
|
|
|
| |
Vifor Pharma |
Canada |
|
|
|
| |
Warburg PSites Pharma |
Germany |
|
|
|
 |
Xention |
United Kingdom |
|
|
|
 |
XOMA
(NASDAQ:XOMA) |
United States |
|
|
|
 |
ZIOPHARM Oncology, Inc.
(NASDAQ:ZIOP) |
United States |
|
|
|
 |
Zymeworks Inc. |
Canada |
|
|
|
